SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 110 filers reported holding SUTRO BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $2,073,000 | -21.1% | 139,331 | 0.0% | 0.46% | -27.1% |
| Q3 2021 | $2,629,000 | +1.5% | 139,331 | 0.0% | 0.63% | -7.3% |
| Q2 2021 | $2,590,000 | -18.3% | 139,331 | 0.0% | 0.68% | -18.5% |
| Q1 2021 | $3,171,000 | +5.2% | 139,331 | 0.0% | 0.84% | +1.9% |
| Q4 2020 | $3,014,000 | +115.7% | 139,331 | 0.0% | 0.82% | +82.5% |
| Q3 2020 | $1,397,000 | +27.3% | 139,331 | 0.0% | 0.45% | +23.6% |
| Q2 2020 | $1,097,000 | -20.2% | 139,331 | 0.0% | 0.36% | -41.8% |
| Q1 2020 | $1,375,000 | -10.0% | 139,331 | 0.0% | 0.63% | +14.0% |
| Q4 2019 | $1,528,000 | +20.9% | 139,331 | 0.0% | 0.55% | -5.8% |
| Q3 2019 | $1,264,000 | -23.0% | 139,331 | -4.0% | 0.58% | -4.1% |
| Q2 2019 | $1,642,000 | -1.7% | 145,154 | -1.0% | 0.61% | -1.3% |
| Q1 2019 | $1,670,000 | +58.7% | 146,653 | 0.0% | 0.62% | -5.5% |
| Q4 2018 | $1,052,000 | -37.6% | 146,653 | 0.0% | 0.65% | -18.5% |
| Q3 2018 | $1,686,000 | – | 146,653 | – | 0.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
| Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
| Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
| Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
| BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
| Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
| Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |